Quarterly report pursuant to Section 13 or 15(d)

Segment and Geographic Information (Tables)

v3.24.3
Segment and Geographic Information (Tables)
9 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Schedule of Certain Financial Data by Reportable Segment
The following tables reflect certain financial data of the Company’s reportable segments:
Three Months Ended September 30, Nine Months Ended September 30,
2024 2023 2024 2023
Segment revenue
Passenger
$ 38,815  $ 37,995  $ 83,907  $ 83,089 
Medical
36,062  33,447  110,429  94,613 
Total revenue
$ 74,877  $ 71,442  $ 194,336  $ 177,702 
Segment Adjusted EBITDA
Passenger $ 5,593  $ 2,777  $ 3,724  $ (2,353)
Medical 3,851  3,346  13,784  8,249 
Total Segment Adjusted EBITDA
9,444  6,123  17,508  5,896 
Reconciling items:
Adjusted unallocated corporate expenses and software development (1) (5,264) (5,336) (15,916) (17,281)
Depreciation and amortization (1,279) (1,843) (4,432) (5,305)
Stock-based compensation (5,345) (3,330) (15,434) (9,348)
Change in fair value of warrant liabilities (299) 5,719  2,266  3,823 
Realized loss from sales of short-term investments —  —  —  (95)
Interest income 1,764  2,147  5,624  6,178 
Legal and regulatory advocacy fees (2)(3) (165) (217) (427) (640)
Executive severance costs (140) —  (140) (265)
SOX readiness costs (220) (145) (302) (180)
Contingent consideration compensation (earn-out) (4) —  (2,700) —  (5,361)
M&A transaction costs (85) —  (169) — 
Impairment of intangible assets —  —  (5,759) — 
Restructuring costs - Blade Europe (5)
(483) —  (483) — 
(Loss) income before income taxes $ (2,072) $ 418  $ (17,664) $ (22,578)
(1) Includes costs that are not directly attributable to reportable segments such as finance, accounting, tax, information technology, human resources, legal costs and software development costs (primarily consists of staff and contractors costs), and excludes non-cash items and certain transactions that management does not believe are reflective of our ongoing core operations.
(2) For the three and nine months ended September 30, 2024, represents legal advocacy fees related to the Drulias lawsuit (see “— Legal and Environmental” within Note 11) that we do not consider representative of legal and regulatory advocacy costs that we will incur from time to time in the ordinary course of our business.
(3) For the three and nine months ended September 30, 2023, represents certain legal and regulatory advocacy fees for certain proposed restrictions at East Hampton Airport and potential operational restrictions on large jet aircraft at Westchester Airport, that we do not consider representative of legal and regulatory advocacy costs that we will incur from time to time in the ordinary course of our business.
(4) Trinity’s contingent consideration, 2023 was the last year subject to an earn-out payment.
(5) Includes severance, retention, legal and other one-time restructuring costs associated with a reorganization of Blade Europe.
September 30,
2024
December 31,
2023
Goodwill
Passenger $ 27,412  $ 27,045 
Medical 15,540  13,328 
Total goodwill $ 42,952  $ 40,373 
Summary of Financial Data Attributable to Various Geographic Regions Summary financial data attributable to various geographic regions for the periods indicated is as follows:
Three Months Ended September 30, Nine Months Ended September 30,
2024 2023 2024 2023
Revenue
United States
$ 63,282  $ 58,630  $ 166,583  $ 148,620 
Other
11,595  12,812  27,753  29,082 
Total revenue
$ 74,877  $ 71,442  $ 194,336  $ 177,702 
September 30,
2024
December 31,
2023
Long-lived assets
United States
$ 38,708  $ 13,727 
Other
14,655  12,656 
Total long-lived assets
$ 53,363  $ 26,383